Bluefin Trading, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.

Quarter-by-quarter ownership
Bluefin Trading, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2017$1,097,000
-56.5%
888,500
+8.8%
0.07%
-77.4%
Q3 2017$2,521,000
-4.5%
816,300
-10.9%
0.30%
+4.2%
Q2 2017$2,640,000
-39.2%
916,400
+3.8%
0.28%
-49.7%
Q1 2017$4,343,000
-55.8%
882,500
-39.2%
0.57%
-6.3%
Q4 2016$9,827,000
+47.1%
1,452,600
-4.9%
0.60%
+146.9%
Q3 2016$6,680,000
-50.6%
1,526,700
-50.5%
0.24%
-81.7%
Q2 2016$13,515,000
-30.8%
3,086,700
+11.2%
1.34%
-31.6%
Q1 2016$19,524,000
-14.1%
2,774,700
+146.8%
1.96%
+7.9%
Q4 2015$22,736,000
-18.7%
1,124,241
+80.2%
1.82%
+6.5%
Q3 2015$27,964,000
+400.1%
623,985
+401.8%
1.71%
+402.1%
Q2 2015$5,592,000
-6.9%
124,357
-55.8%
0.34%
-38.2%
Q1 2015$6,008,000
-79.3%
281,594
-72.6%
0.55%
-68.3%
Q4 2014$28,980,000
+10.4%
1,028,898
-8.9%
1.74%
+20.7%
Q3 2014$26,255,000
+297.8%
1,128,939
+11311.5%
1.44%
+406.7%
Q2 2014$6,600,000
+230.0%
9,893
+632.8%
0.28%
+51.9%
Q3 2013$2,000,0001,3500.19%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2015
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,586,582$864,160,00032.02%
FARLEY CAPITAL L.P. 341,518$44,807,00030.12%
LeVasseur Capital Partners LLC 190,404$24,981,00029.94%
Ruane, Cunniff & Goldfarb 34,494,015$4,525,615,00023.97%
ValueAct Holdings 18,923,877$2,482,813,00016.64%
White River Investment Partners, LLC 90,099$11,820,00016.35%
Tesuji Partners 1,368,040$179,487,00015.45%
Arrow Capital Management, LLC 197,500$25,912,00015.11%
Hound Partners 3,576,998$469,302,00014.87%
Brahman Capital Corp. 4,457,153$584,778,00012.82%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders